Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 21, 2019
[ Thu, Nov 21st 2019
] - WOPRAI
Wed, November 20, 2019
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
[ Wed, Nov 20th 2019
] - WOPRAI
Andrew Baum Maintained (ABBV) at Strong Buy with Increased Target to $98 on, Nov 20th, 2019
Andrew Baum of Citigroup, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $90 to $98 on, Nov 20th, 2019.
Andrew has made no other calls on ABBV in the last 4 months.
There is 1 other peer that has a rating on ABBV. Out of the 1 peers that are also analyzing ABBV, 0 agree with Andrew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andrew
- Marc Goodman of "UBS" Maintained at Strong Buy with Increased Target to $96 on, Tuesday, November 19th, 2019
